# FDA 483 - Richard B. Powell, MD - May 24, 2023

Source: https://www.keypedia.com/records/483/richard-b-powell-md/1052df16-325e-4d6c-a47e-b80a4b19fb40

> FDA 483 for Richard B. Powell, MD on May 24, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Richard B. Powell, MD
- Inspection Date: 2023-05-24
- Product Type: drugs
- Office Name: Cincinnati District Office
- Summary: Richard B. Powell, MD, a clinical investigator in Cincinnati, OH, was cited for significant deficiencies in conducting investigational studies. The inspection revealed failures to adhere to investigational plans, including incorrect subject dosing, out-of-window drug administration, and critical delays in reporting serious adverse events, including a subject's death. Additionally, the firm failed to maintain accurate case histories, with missing dosing records and unreported concomitant medications for multiple subjects.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/kathryn-l-suttling/2d4695ca-5ec3-4658-8f46-101cec4ca41d)
- [investigator](https://www.keypedia.com/people/yvette-m-lacour-davis/8bae7c3f-2c46-4bf0-9e77-beaa25cdad91)

Company: https://www.keypedia.com/companies/richard-b-powell-md/bfb124aa-5bc2-4344-a7a2-917218effad6

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22